Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Anti-Thyroid Drugs Market Today And What Is Its Future Size?

In recent years, the market size for anti-thyroid drugs has seen a slight increase. The market is projected to expand from $2.46 billion in 2024 to $2.49 billion in 2025, experiencing a compound annual growth rate (CAGR) of 1.2%. Factors contributing to this growth during the historic period include the prevalence of thyroid disorders, progress in drug development, and healthcare infrastructure.

The market size for anti-thyroid drugs is set for consistent expansion in the forthcoming years. Projected to surge to “$2.76 billion by 2029”, the market is set to achieve a compound annual growth rate (CAGR) of 2.6%. The predicted growth during the forecast period is due to factors such as increased patient awareness and education, healthcare spending, patient demographics, and the global economic environment. Key trends in this forecast period include alternatives to thyroid surgery and radioactive iodine, a focus on patient-centric care, and the integration of telemedicine and remote monitoring.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Anti-Thyroid Drugs Market?

The prevalence of Graves’ disease, a key contributor to hyperthyroidism, is on the rise. The National Library of Medicine, a biomedical repository overseen by the United States Federal Government, suggests that in developed nations, Graves’ disease (GD) is the leading cause of hyperthyroidism. Those aged between 30 and 60 are most susceptible to the disease, with women 5-10 times more prone than men. Factors such as genetic predisposition contribute to 79% of the GD risk while the environment accounts for a 21% risk. The augmentation in cases of Graves’ disease corresponds to an increase in individuals suffering from hyperthyroidism. As a result, the demand for anti-thyroid drugs is escalating, fuelling market growth.

How Is The Anti-Thyroid Drugs Market Categorized Across Applications And Types?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

How Are Market Trends Influencing Competition In The Anti-Thyroid Drugs Market?

Organizations focused on thyroid health are initiating efforts to increase awareness about thyroid conditions, share recent advancements in treatment and relay findings from various thyroid-related research studies. In the USA, an estimated 60% of individuals with hyperthyroidism are not aware of their condition and remain undiagnosed. To address these problems, organizations like the American Thyroid Association (ATA) are playing a pivotal role in educating the populace about thyroid conditions. Likewise, the Thyroid Foundation of Canada is also pioneering public engagement and consciousness increase with regard to thyroid diseases including hyperthyroidism. Other groups, such as the American Academy of Otolaryngology and the British Thyroid Foundation, are also launching their own initiatives and awareness campaigns.

Which Firms Are Making The Biggest Impact In The Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Region Holds The Greatest Opportunity For Anti-Thyroid Drugs Market Expansion?

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model